UNSPSC 51413001: Aminoethyl nitrate

This classification denotes a vasodilating agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S1IA7R2J48. European Medicines Agency schedules Aminoethyl nitrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05439MIG. Aminoethyl nitrate generally arises in the molecular formula C2H6N2O3. The term AMINOETHYL NITRATE is an International Non-Proprietary Name or INN. Most nations schedule aminoethyl nitrate under HS 29225000 and SITC 51467.

As of Q4 2014, AMINOETHYL NITRATE remains the US FDA Preferred Term for this commodity. Aminoethyl nitrate bears US NLM identifiers UMLS ID C2698088 and NCI Concept Code C74414. SMILES: O([N](=O)O)CCN.

UNSPSC 51413001 Aminoethyl nitrate is a Commodity code that covers specific pharmaceutical ingredients and medications used in emergency medical response and clinical settings. State and local governments procure under this code primarily through fire rescue departments, health and human services agencies, and cooperative purchasing alliances seeking to supply emergency life support medications, generic pharmaceuticals, and over-the-counter products for use by paramedics, hospital systems, and public health programs. The issuing bodies span city purchasing departments (notably the City of Tampa's fire rescue procurement), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, which serves participating state and local facilities across multiple jurisdictions including Oregon). Scope includes sealed competitive bids for specific medication line items with strict expiration-date warranties, direct-to-manufacturer pharmacy initiatives, and generic multi-source pharmaceutical contracts requiring compliance with FDA standards, Good Manufacturing Practices, and Drug Supply Chain Security Act requirements.

Recent activity clusters in Florida and Texas, with multistate cooperative procurement extending across Minnesota and Oregon. Representative solicitations include the City of Tampa Fire Rescue's sealed-bid procurement (Bid No. 26-P-00188, due April 8, 2026) for Advanced Life Support Medications totaling approximately $40,000 covering Labetalol, Epinephrine, Adenosine, and Diltiazem with a 5 percent Small Local Business Enterprise bid discount; the Texas HHS Commission's Request for Information (RFI No. HHS0017013, April 3, 2026 deadline) exploring direct-to-manufacturer pharmacy partnerships outside traditional pharmacy benefit manager and group purchasing organization channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products through three authorized wholesalers effective July 1, 2026, with weighted evaluation emphasizing price competitiveness (75 percent) and compliance with manufacturing and supply-chain security certifications.